A Therapeutic Dose of FK506 Does Not Affect Collagen Turnover Pathways in Healthy Human Gingival Fibroblasts

N. Gagliano, C. Moscheni, G. M. Tartaglia, S. Selleri, M. Chiriva-Internati, E. Cobos, C. Torri, F. Costa, L. Pettinari, M. Gioia

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We previously demonstrated that a high dose of tacrolimus (1 μmol/L) induced expression of matrix metalloproteinase (MMP) proteins in human cultured gingival fibroblasts, suggesting a molecular mechanism maintaining gingival collagen homeostasis in tacrolimus-treated patients. Herein we have analyzed whether the effect on collagen turnover might be influenced by a therapeutic tacrolimus dose. Human gingival fibroblasts were incubated for 72 hours with 10 nmol/L, 100 nmol/L, and 1 μmol/L tacrolimus, or left untreated (CT). Collagen type I and III (COL-I, COL-III), lysyl hydroxylase 2b (LH2b), MMP-1 and -2, tissue inhibitor of MMP-1 and transforming growth factor-β1 (TGF-β1) mRNA levels were assayed by reverse-transcriptase polymerase chain reaction, collagen protein levels by dot blot, and MMP activity by sodium dodecyl sulfate zymography. Tacrolimus did not affect COL-I, COL-III, or MMP gene expression, while LH2b and TGF-β1 tended to be down-regulated after 1 μmol/L FK506. Conversely, protein levels of MMP-1 (P = NS) and MMP-2 (P <.05 vs CT, 10 nmol/L, 100 nmol/L) were up-regulated after 1 μmol/L tacrolimus. Our findings confirmed that a high dose of tacrolimus does not induce interstitial collagen overexpression by gingival fibroblasts and induces up-regulation of MMPs protein levels. Interestingly, at doses corresponding to whole blood trough levels, tacrolimus did not exert any evident effect on collagen turnover pathways, suggesting that tacrolimus is likely to not affect collagen homeostasis in the gingival connective tissue compartment of FK506-immunosuppressed subjects. This effect did not seem to be dose-dependent.

Original languageEnglish
Pages (from-to)1419-1424
Number of pages6
JournalTransplantation Proceedings
Volume40
Issue number5
DOIs
Publication statusPublished - Jun 2008

Fingerprint

Tacrolimus
Collagen
Fibroblasts
Matrix Metalloproteinases
Matrix Metalloproteinase 1
2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine
Therapeutics
Matrix Metalloproteinase 2
Transforming Growth Factors
Proteins
Homeostasis
Tissue Inhibitor of Metalloproteinase-1
Collagen Type III
Collagen Type I
Reverse Transcriptase Polymerase Chain Reaction
Sodium Dodecyl Sulfate
Connective Tissue
Up-Regulation
Gene Expression
Messenger RNA

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Gagliano, N., Moscheni, C., Tartaglia, G. M., Selleri, S., Chiriva-Internati, M., Cobos, E., ... Gioia, M. (2008). A Therapeutic Dose of FK506 Does Not Affect Collagen Turnover Pathways in Healthy Human Gingival Fibroblasts. Transplantation Proceedings, 40(5), 1419-1424. https://doi.org/10.1016/j.transproceed.2008.03.140

A Therapeutic Dose of FK506 Does Not Affect Collagen Turnover Pathways in Healthy Human Gingival Fibroblasts. / Gagliano, N.; Moscheni, C.; Tartaglia, G. M.; Selleri, S.; Chiriva-Internati, M.; Cobos, E.; Torri, C.; Costa, F.; Pettinari, L.; Gioia, M.

In: Transplantation Proceedings, Vol. 40, No. 5, 06.2008, p. 1419-1424.

Research output: Contribution to journalArticle

Gagliano, N, Moscheni, C, Tartaglia, GM, Selleri, S, Chiriva-Internati, M, Cobos, E, Torri, C, Costa, F, Pettinari, L & Gioia, M 2008, 'A Therapeutic Dose of FK506 Does Not Affect Collagen Turnover Pathways in Healthy Human Gingival Fibroblasts', Transplantation Proceedings, vol. 40, no. 5, pp. 1419-1424. https://doi.org/10.1016/j.transproceed.2008.03.140
Gagliano, N. ; Moscheni, C. ; Tartaglia, G. M. ; Selleri, S. ; Chiriva-Internati, M. ; Cobos, E. ; Torri, C. ; Costa, F. ; Pettinari, L. ; Gioia, M. / A Therapeutic Dose of FK506 Does Not Affect Collagen Turnover Pathways in Healthy Human Gingival Fibroblasts. In: Transplantation Proceedings. 2008 ; Vol. 40, No. 5. pp. 1419-1424.
@article{ff0d07da09a14a17ac7bf7f48a9cb38b,
title = "A Therapeutic Dose of FK506 Does Not Affect Collagen Turnover Pathways in Healthy Human Gingival Fibroblasts",
abstract = "We previously demonstrated that a high dose of tacrolimus (1 μmol/L) induced expression of matrix metalloproteinase (MMP) proteins in human cultured gingival fibroblasts, suggesting a molecular mechanism maintaining gingival collagen homeostasis in tacrolimus-treated patients. Herein we have analyzed whether the effect on collagen turnover might be influenced by a therapeutic tacrolimus dose. Human gingival fibroblasts were incubated for 72 hours with 10 nmol/L, 100 nmol/L, and 1 μmol/L tacrolimus, or left untreated (CT). Collagen type I and III (COL-I, COL-III), lysyl hydroxylase 2b (LH2b), MMP-1 and -2, tissue inhibitor of MMP-1 and transforming growth factor-β1 (TGF-β1) mRNA levels were assayed by reverse-transcriptase polymerase chain reaction, collagen protein levels by dot blot, and MMP activity by sodium dodecyl sulfate zymography. Tacrolimus did not affect COL-I, COL-III, or MMP gene expression, while LH2b and TGF-β1 tended to be down-regulated after 1 μmol/L FK506. Conversely, protein levels of MMP-1 (P = NS) and MMP-2 (P <.05 vs CT, 10 nmol/L, 100 nmol/L) were up-regulated after 1 μmol/L tacrolimus. Our findings confirmed that a high dose of tacrolimus does not induce interstitial collagen overexpression by gingival fibroblasts and induces up-regulation of MMPs protein levels. Interestingly, at doses corresponding to whole blood trough levels, tacrolimus did not exert any evident effect on collagen turnover pathways, suggesting that tacrolimus is likely to not affect collagen homeostasis in the gingival connective tissue compartment of FK506-immunosuppressed subjects. This effect did not seem to be dose-dependent.",
author = "N. Gagliano and C. Moscheni and Tartaglia, {G. M.} and S. Selleri and M. Chiriva-Internati and E. Cobos and C. Torri and F. Costa and L. Pettinari and M. Gioia",
year = "2008",
month = "6",
doi = "10.1016/j.transproceed.2008.03.140",
language = "English",
volume = "40",
pages = "1419--1424",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - A Therapeutic Dose of FK506 Does Not Affect Collagen Turnover Pathways in Healthy Human Gingival Fibroblasts

AU - Gagliano, N.

AU - Moscheni, C.

AU - Tartaglia, G. M.

AU - Selleri, S.

AU - Chiriva-Internati, M.

AU - Cobos, E.

AU - Torri, C.

AU - Costa, F.

AU - Pettinari, L.

AU - Gioia, M.

PY - 2008/6

Y1 - 2008/6

N2 - We previously demonstrated that a high dose of tacrolimus (1 μmol/L) induced expression of matrix metalloproteinase (MMP) proteins in human cultured gingival fibroblasts, suggesting a molecular mechanism maintaining gingival collagen homeostasis in tacrolimus-treated patients. Herein we have analyzed whether the effect on collagen turnover might be influenced by a therapeutic tacrolimus dose. Human gingival fibroblasts were incubated for 72 hours with 10 nmol/L, 100 nmol/L, and 1 μmol/L tacrolimus, or left untreated (CT). Collagen type I and III (COL-I, COL-III), lysyl hydroxylase 2b (LH2b), MMP-1 and -2, tissue inhibitor of MMP-1 and transforming growth factor-β1 (TGF-β1) mRNA levels were assayed by reverse-transcriptase polymerase chain reaction, collagen protein levels by dot blot, and MMP activity by sodium dodecyl sulfate zymography. Tacrolimus did not affect COL-I, COL-III, or MMP gene expression, while LH2b and TGF-β1 tended to be down-regulated after 1 μmol/L FK506. Conversely, protein levels of MMP-1 (P = NS) and MMP-2 (P <.05 vs CT, 10 nmol/L, 100 nmol/L) were up-regulated after 1 μmol/L tacrolimus. Our findings confirmed that a high dose of tacrolimus does not induce interstitial collagen overexpression by gingival fibroblasts and induces up-regulation of MMPs protein levels. Interestingly, at doses corresponding to whole blood trough levels, tacrolimus did not exert any evident effect on collagen turnover pathways, suggesting that tacrolimus is likely to not affect collagen homeostasis in the gingival connective tissue compartment of FK506-immunosuppressed subjects. This effect did not seem to be dose-dependent.

AB - We previously demonstrated that a high dose of tacrolimus (1 μmol/L) induced expression of matrix metalloproteinase (MMP) proteins in human cultured gingival fibroblasts, suggesting a molecular mechanism maintaining gingival collagen homeostasis in tacrolimus-treated patients. Herein we have analyzed whether the effect on collagen turnover might be influenced by a therapeutic tacrolimus dose. Human gingival fibroblasts were incubated for 72 hours with 10 nmol/L, 100 nmol/L, and 1 μmol/L tacrolimus, or left untreated (CT). Collagen type I and III (COL-I, COL-III), lysyl hydroxylase 2b (LH2b), MMP-1 and -2, tissue inhibitor of MMP-1 and transforming growth factor-β1 (TGF-β1) mRNA levels were assayed by reverse-transcriptase polymerase chain reaction, collagen protein levels by dot blot, and MMP activity by sodium dodecyl sulfate zymography. Tacrolimus did not affect COL-I, COL-III, or MMP gene expression, while LH2b and TGF-β1 tended to be down-regulated after 1 μmol/L FK506. Conversely, protein levels of MMP-1 (P = NS) and MMP-2 (P <.05 vs CT, 10 nmol/L, 100 nmol/L) were up-regulated after 1 μmol/L tacrolimus. Our findings confirmed that a high dose of tacrolimus does not induce interstitial collagen overexpression by gingival fibroblasts and induces up-regulation of MMPs protein levels. Interestingly, at doses corresponding to whole blood trough levels, tacrolimus did not exert any evident effect on collagen turnover pathways, suggesting that tacrolimus is likely to not affect collagen homeostasis in the gingival connective tissue compartment of FK506-immunosuppressed subjects. This effect did not seem to be dose-dependent.

UR - http://www.scopus.com/inward/record.url?scp=45449118290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45449118290&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2008.03.140

DO - 10.1016/j.transproceed.2008.03.140

M3 - Article

C2 - 18589121

AN - SCOPUS:45449118290

VL - 40

SP - 1419

EP - 1424

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 5

ER -